Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Inappropriate discontinuation of drug treatment and noncompliance are a leading cause of long-term morbidity during treatment of depression. Increasing evidence supports an association between depressive illness and disturbances in brain glutamate activity, nitric oxide synthesis, and gamma-amino butyric acid. Animal models also confirm that suppression of glutamate N-methyl-D-aspartate receptor activity or inhibition of the nitric oxide-cyclic guanosine monophosphate pathway, as well as increasing brain levels of gamma-amino butyric acid, may be key elements in antidepressant action. Imaging studies demonstrate, for the most part, decreased hippocampal volume in patients with depression, which may worsen with recurrent depressive episodes. Preclinical models link this potentially neurodegenerative pathology to continued stress-evoked synaptic remodeling, driven primarily by the release of glucocorticoids, glutamate, and nitric oxide. These stress-induced structural changes can be reversed by antidepressant treatment. In patients with depression, antidepressant withdrawal after chronic administration is associated with a stress response as well as functional and neurochemical changes. Preclinical data also show that antidepressant withdrawal evokes a behavioral stress response that is associated with increased hippocampal N-methyl-D-aspartate receptor density, with both responses dependent on N-methyl-D-aspartate receptor activation. Drawing from both clinical and preclinical studies, this article proposes a preliminary molecular perspective and hypothesis on the neuronal implications of adherence to and discontinuation of antidepressant medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
STRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087
Self-citationGlucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.999 · Cited by 1,848
Hippocampal Volume Reduction in Major Depression
Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.115 · Cited by 1,670
Vyas, A., Mitra, R., Shankaranarayana Rao, B. S., & Chattarji, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06810.2002 · Cited by 1,662
Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma
Gilbertson, M. W., Shenton, M. E., Ciszewski, A., Kasai, K., Lasko, N. B., Orr, S. P., & Pitman, R. K. (2002) · Nature Neuroscience · doi:10.1038/nn958 · Cited by 1,635
Gould, E., Tanapat, P., McEwen, B. S., Flügge, G., & Fuchs, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3168 · Cited by 1,395
Self-citationSheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382
Course of illness, hippocampal function, and hippocampal volume in major depression
MacQueen, G. M., Campbell, S., McEwen, B. S., Macdonald, K., Amano, S., Joffe, R. T., Nahmias, C., & Young, L. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337481100 · Cited by 980
Self-citation
Research works printed but not linked: 96
- Abercrombie, 1998, Metabolic rate in the right amygdala predicts negative affect in depressed patients, Neuroreport, 9, 3301, 10.1097/00001756-199810050-00028 · DOI · Paper page
- Altshuler, 1998, Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia, Arch Gen Psychiatry, 55, 663
- Anthony, 2000, Antidepressant-induced regulation of 5HT1B mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation, J Neurosci Res, 61, 82, 10.1002/1097-4547(20000701)61:1<82::AID-JNR10>3.0.CO;2-E · DOI
- Basco, 1995, Compliance of pharmacotherapy in mood disorder, Psychiatr Ann, 25, 269, 10.3928/0048-5713-19950501-03 · DOI
- Bell, 2001, Tryptophan depletion and its implications for psychiatry, Br J Psychiatry, 178, 399, 10.1192/bjp.178.5.399 · DOI · Paper page
- Berk, 2001, Platelet glutamate receptor supersensitivity in major depressive disorder, Clin Neuropharmacol, 24, 129, 10.1097/00002826-200105000-00002 · DOI
- Bernstein, 1998, Nitric oxide synthase-containing neurons in the human hypothalamus, Neuroscience, 83, 867, 10.1016/S0306-4522(97)00461-2 · DOI · Paper page
- Bourdeau, 2002, Loss of brain volume in endogenous Cushing’s syndrome and its reversibility after correction of hypercortisolism, J Clin Endocrinol Metab, 87, 1949
- Boyer, 1998, Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain, J Mol Neurosci, 10, 219, 10.1007/BF02761776 · DOI
- Chrousos, 1992, The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis, JAMA, 267, 1244, 10.1001/jama.1992.03480090092034 · DOI · Paper page
- Czeh, 2001, Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine, Proc Natl Acad Sci U S A, 98, 12796, 10.1073/pnas.211427898 · DOI · Paper page
- Dall’Olio, 2000, D-cycloserine, a positve modulator of NMDA receptors, inhibits serotonergic function, Behav Pharmacol, 11, 631, 10.1097/00008877-200011000-00010 · DOI
- de Oliviera, 2000, Expression of neuronal nitric oxide synthase mRNA in stress-related brain areas after restraint in rats, Neurosci Lett, 289, 123, 10.1016/S0304-3940(00)01287-8 · DOI
- De Paermentier, 1997, Brain alpha-adrenoceptors in depressed suicides, Brain Res, 757, 60, 10.1016/S0006-8993(97)00138-8 · DOI
- Di Cara, 2001, Serotonin depletion produces long-lasting increase in striatal glutamatergic transmission, J Neurochem, 78, 240, 10.1046/j.1471-4159.2001.00242.x · DOI
- Dilsaver, 1989, Antidepressant withdrawal syndromes, Acta Psychiatr Scand, 79, 113, 10.1111/j.1600-0447.1989.tb08578.x · DOI · Paper page
- Dowlatshahi, 1999, G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders, J Neurochem, 73, 1121, 10.1046/j.1471-4159.1999.0731121.x · DOI
- Dowlatshahi, 1998, Increased temporal cortex CREB concentrations and antidepressant treatment in major depression, Lancet, 352, 1754, 10.1016/S0140-6736(05)79827-5 · DOI · Paper page
- Drevets, 1997, Subgenual prefrontal cortex abnormalities in mood disorders, Nature, 386, 824, 10.1038/386824a0 · DOI · Paper page
- D’Sa, 2002, Antidepressants and neuroplasticity, Bipolar Disord, 4, 184
- Engelmann, 2002, Release patterns of excitatory and inhibitory amino acids within the hypothalamic supraoptic nucleus in response to direct nitric oxide administration during forced swimming in rats, Neurosci Lett, 324, 252, 10.1016/S0304-3940(02)00211-2 · DOI
- Golembiowska, 2000, Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex, Pol J Pharmacol, 52, 441
- Greden, 1993, Antidepressant maintenance medications, J Clin Psychiatry, 54, 39
- Harkin, 2000, Noradrenergic lesion antagonises desimipramine-induced adaptation of NMDA receptors, Eur J Pharmacol, 389, 187, 10.1016/S0014-2999(99)00923-1 · DOI
- Harkin, 1999, Nitric oxide synthase inhibitors have antidepressant-like properties in mice, Eur J Pharmacol, 372, 207, 10.1016/S0014-2999(99)00191-0 · DOI · Paper page
- Harvey, 1996, Affective disorders and nitric oxide, Hum Psychopharmacol, 11, 309, 10.1002/(SICI)1099-1077(199607)11:4<309::AID-HUP775>3.0.CO;2-B · DOI
- Harvey, 1997, The neurobiology and pharmacology of depression, S Afr Med J, 87, 540
- Harvey, 2002, NMDA receptor involvement in imipramine withdrawal-associated effects on swim stress, GABA levels and NMDA receptor binding in rat hippocampus, Life Sci, 71, 43, 10.1016/S0024-3205(02)01561-8 · DOI · Paper page
- Heiberg, 2002, Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats, Behav Brain Res, 134, 479, 10.1016/S0166-4328(02)00084-0 · DOI
- Henry, 2003, Cerebral blood volume and clinical changes on the third day of placebo substitution for SSRI treatment, Biol Psychiatry, 53, 100, 10.1016/S0006-3223(02)01441-5 · DOI
- Ichimiya, 2002, Serotonin transporter binding in patients with mood disorders, Biol Psychiatry, 51, 715, 10.1016/S0006-3223(01)01351-8 · DOI · Paper page
- Ishizuka, 2000, GABA(A) and GABA(B) receptors modulating basal and footshock-induced nitric oxide releases in rat prefrontal cortex, Brain Res, 872, 266, 10.1016/S0006-8993(00)02508-7 · DOI
- Izumi, 2002, Glutamate transporters and retinal excitotoxicity, Glia, 39, 58, 10.1002/glia.10082 · DOI
- Kasper, 2002, Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette’s disorder-implications for psychopharmacology, World J Biol Psychiatry, 3, 133, 10.3109/15622970209150614 · DOI · Paper page
- Kaufman MJ, Henry ME, Blaise F, Hennen J, Villafurete RA, Stoddard E, et al (2003): Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: A proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 54:534–539 · DOI
- Keller, 1998, Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression, Biol Psychiatry, 44, 348, 10.1016/S0006-3223(98)00110-3 · DOI · Paper page
- Keller, 2002, Optimizing outcomes in depression, Int Clin Psychopharmacol, 17, 265, 10.1097/00004850-200211000-00001 · DOI · Paper page
- Kim, 2002, Changes of GABAA receptor binding and subunit mRNA level in rat brain by infusion of NOS inhibitor, Brain Res, 952, 246, 10.1016/S0006-8993(02)03248-1 · doi:10.1016/s0006-8993(02)03248-1
- Kroczka, 2001, Antidepressant-like properties of zinc in rodent forced swim test, Brain Res Bull, 55, 297, 10.1016/S0361-9230(01)00473-7 · DOI · Paper page
- Krukoff, 1997, Stress-induced activation of nitric oxide-producing neurons in the rat brain, J Comp Neurol, 377, 509, 10.1002/(SICI)1096-9861(19970127)377:4<509::AID-CNE3>3.0.CO;2-6 · DOI
- Kuhn, 2002, Chronic course and psychosocial disability caused by depressive illnesses in general practice patients during a one year period. Results of a study by the World Health Organization, Nervenarzt, 73, 644
- Law, 2001, Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses, Neuroreport, 12, 2971, 10.1097/00001756-200109170-00043 · DOI · Paper page
- Lee, 2001, Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats, Mol Psychiatry, 6, 725, 10.1038/sj.mp.4000947 · DOI · Paper page
- Lievens, 2001, Impaired glutamate uptake in the R6 Huntington’s disease transgenic mice, Neurobiol Dis, 8, 807, 10.1006/nbdi.2001.0430 · DOI · Paper page
- Lowy, 1993, Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus, J Neurochem, 61, 1957, 10.1111/j.1471-4159.1993.tb09839.x · DOI · Paper page
- Lucassen, 2001, Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure, Am J Pathol, 158, 453, 10.1016/S0002-9440(10)63988-0 · DOI · Paper page
- Maes, 1994, Hypozincemia in depression, J Affect Disord, 31, 135, 10.1016/0165-0327(94)90117-1 · DOI · Paper page
- Maes, 1998, Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression, Acta Psychiatr Scand, 97, 302, 10.1111/j.1600-0447.1998.tb10004.x · DOI · Paper page
- Malberg, 1999, Chronic antidepressant administration increases granule cell proliferation in the hippocampus of the adult male rat, Abstr Soc Neurosci, 25, 1029
- Manier, 2000, Human fibroblasts as a relevant model to study signal transduction in affective disorders, J Affect Disord, 61, 51, 10.1016/S0165-0327(99)00190-1 · DOI
- Matute, 2001, The link between excitotoxic oligodendroglial death and demyelinating diseases, Trends Neurosci, 24, 224, 10.1016/S0166-2236(00)01746-X · DOI · Paper page
- Mauri, 1998, Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment, Neuropsychobiology, 37, 124, 10.1159/000026491 · DOI · Paper page
- McCullumsmith, 2002, Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder, Neuropsychopharmacology, 26, 368, 10.1016/S0893-133X(01)00370-0 · DOI · Paper page
- McEwen, 2000, The neurobiology of stress, Brain Res, 886, 172, 10.1016/S0006-8993(00)02950-4 · DOI · Paper page
- McEwen, 1997, Prevention of stress-induced morphological and cognitive consequences, Eur Neuropsychopharmacol, 7, 323, 10.1016/S0924-977X(97)00064-3 · DOI
- McLeod, 2001, Nitric oxide, stress, and depression, Psychopharmacol Bull, 35, 24
- Mervaala, 2000, Quantitative MRI of the hippocampus and amygdala in severe depression, Psychol Med, 30, 117, 10.1017/S0033291799001567 · DOI · Paper page
- Michelson, 2000, Hormonal markers of stress response following interruption of selective serotonin reupake inhibitor treatment, Psychoneuroendocrinology, 25, 169, 10.1016/S0306-4530(99)00046-3 · DOI
- Miller, 1994, Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP, J Biol Chem, 269, 27351, 10.1016/S0021-9258(18)46992-X · DOI · Paper page
- Mischoulon, 2002, An open lable pilot study of nefazodone in depression with anger attacks, Psychiatry Res, 116, 151, 10.1016/S0925-4927(02)00082-3 · DOI
- Miyamoto, 2002, Lower sensitivity to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor epsilon 4 subunit, J Neurosci, 22, 2335, 10.1523/JNEUROSCI.22-06-02335.2002 · DOI · Paper page
- Moore, 2000, Lithium increases N-acetyl-aspartate in the human brain, Biol Psychiatry, 48, 1, 10.1016/S0006-3223(00)00252-3 · DOI · Paper page
- Nierenberg, 2001, Long-term management of chronic depression, J Clin Psychiatry, 62, 17
- Nowak, 1995, Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims, Brain Res, 675, 157, 10.1016/0006-8993(95)00057-W · DOI · Paper page
- Ohkuma, 1995, Nitric oxide-induced, J Neurochem, 65, 1109, 10.1046/j.1471-4159.1995.65031109.x · doi:10.1046/j.1471-4159.1995.65031109.x
- Pandey, 1997, Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects, Psychiatry Res, 71, 137, 10.1016/S0165-1781(97)00060-7 · DOI
- Paul, 2001, Antidepressant activity and calcium signaling cascades, Hum Psychopharmacol, 16, 71, 10.1002/hup.186 · DOI
- Pawlak, 2003, Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior, Nat Neurosci, 6, 168, 10.1038/nn998 · DOI · Paper page
- Pham, 2003, Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus, Eur J Neurosci, 17, 1, 10.1046/j.1460-9568.2003.02513.x · DOI · Paper page
- Popoli, 2002, Modulation of synaptic plasticity by stress and antidepressants, Bipolar Disord, 4, 166, 10.1034/j.1399-5618.2002.01159.x · DOI
- Post, 1998, Sensitization and kindling phenomena in mood, anxiety, and obsessive-compulsive disorders, Biol Psychiatry, 44, 193, 10.1016/S0006-3223(98)00144-9 · DOI · Paper page
- Rajkowska, 2000, Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells, Biol Psychiatry, 48, 766, 10.1016/S0006-3223(00)00950-1 · DOI · Paper page
- Rao, 2001, Antisense knockdown of the glial glutamate transporter GLT-1 exacerbates hippocampal neuronal damage following traumatic injury to rat brain, Eur J Neurosci, 13, 119
- Rasmussen, 2002, Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock, Neuropsychopharmacology, 27, 133, 10.1016/S0893-133X(02)00286-5 · DOI · Paper page
- Rogoz, 2002, Synergistic effects of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats, Neuropharmacology, 42, 1024, 10.1016/S0028-3908(02)00055-2 · DOI · Paper page
- Saransaari, 1997, Enhanced GABA release in cell-damaging conditions in the adult and developing mouse hippocampus, Int J Dev Neurosci, 15, 163, 10.1016/S0736-5748(97)80001-9 · DOI
- Schatzberg, 1997, Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome, J Clin Psychiatry, 58, 23
- Shiah, 1998, GABA function in mood disorders, Life Sci, 63, 1289, 10.1016/S0024-3205(98)00241-0 · DOI
- Skolnick, 1999, Antidepressants for the new millenium, Eur J Pharmacol, 375, 31, 10.1016/S0014-2999(99)00330-1 · DOI · Paper page
- Skolnick, 1996, Adaptation of N-methyl-D-aspartate receptors following antidepressant treatment, Pharmacopsychiatry, 29, 23, 10.1055/s-2007-979537 · DOI · Paper page
- Smith, 1995, Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus, J Neurosci, 15, 1768, 10.1523/JNEUROSCI.15-03-01768.1995 · DOI · Paper page
- Spadone, 2002, Treatment adherence in the recurrent depressive disorders, Encephale, 28, 255
- Starkman, 2001, Elevated cortisol levels in Cushings disease are associated with cognitive decrements, Psychosom Med, 63, 985, 10.1097/00006842-200111000-00018 · DOI · Paper page
- Starkman, 2003, Improvement in learning associated with increase in hippocampal formation volume, Biol Psychiatry, 53, 233, 10.1016/S0006-3223(02)01750-X · DOI
- Stewart, 2002, Antidepressant mechanisms, Mol Psychiatry, 7, S15, 10.1038/sj.mp.4001014 · DOI
- Strakowski, 1999, Brain magnetic resonance imaging of structural abnormalities in bipolar disorder, Arch Gen Psychiatry, 56, 254, 10.1001/archpsyc.56.3.254 · DOI · Paper page
- Stryjer, 2003, Amantadine as augmentation therapy in the management of treatment resistant depression, Int Clin Psychopharmacol, 18, 93, 10.1097/00004850-200303000-00005 · DOI
- Sullivan, 2001, Heritability of hippocampal size in elderly men, Hippocampus, 11, 754, 10.1002/hipo.1091 · DOI · Paper page
- Suzuki, 2001, Elevated plasma nitrate levels in depressive states, J Affect Disord, 63, 221, 10.1016/S0165-0327(00)00164-6 · DOI · Paper page
- Tagliaferro, 2001, Increased nitric oxide synthase activity in a model of serotonin depletion, Brain Res Bull, 54, 199, 10.1016/S0361-9230(00)00450-0 · DOI
- Vaidya, 1999, Role of 5HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus, Neurosci Lett, 262, 1, 10.1016/S0304-3940(99)00006-3 · DOI · Paper page
- Wegener, 2000, Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo, Br J Pharmacol, 130, 575, 10.1038/sj.bjp.0703349 · DOI · Paper page
- Xing, 2002, Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression, Schizophr Res, 58, 21, 10.1016/S0920-9964(01)00388-7 · DOI
- Yamada, 1999, GABAB receptor-mediated presynaptic inhibition of glutamatergic and GABA’ergic transmission in the basolateral amygdala, Neuropharmacology, 38, 1743, 10.1016/S0028-3908(99)00126-4 · DOI
- Yuan, 2000, Apoptosis in the nervous system, Nature, 407, 802, 10.1038/35037739 · DOI · Paper page
- Zetterström, 1999, Manipulations of brain 5HT levels affect gene expression for BDNF in rat brain, Neuropharmacology, 38, 1063, 10.1016/S0028-3908(99)00022-2 · DOI
Cited by
The nature of relapse in schizophrenia
Emsley, R., Chiliza, B., Asmal, L., & Harvey, B. H. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-50 · Cited by 478
Self-citationFava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Renoir, T. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00045 · Cited by 107
“A decade ago, Harvey et al. (2003) highlighted that although significant progress had been made to uncover the pathophysiology of depression and the mechanisms of actions of SSRIs, the neurobiology of SSRI discontinuation syndrome had not been comprehensively addressed.”
BackgroundBrand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95
Self-citation
Metadata
- Authors
- Harvey, B. H., McEwen, B. S., & Stein, D. J.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 54
- Issue
- 10
- Pages
- 1105-1117
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2013321343
- Cited by
- 65
- References
- 33
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- South African Medical Research Council
- National Research Foundation of Korea (2053203)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression. https://app.cochat.ai/papers/10.1016/s0006-3223(03)00528-6
- The paper
- Harvey, B. H., McEwen, B. S., & Stein, D. J. (2003). Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression. Biological Psychiatry. https://doi.org/10.1016/s0006-3223(03)00528-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.